Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of formoterol Cyclohaler capsules vs Foradil in mild to moderate reversible obstructive airway disease
2005-002538-37Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol in asthma (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Time-weighted change in FEV1 to 12 hours post dose. Started Jul 2005; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-002538-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002538-37.